PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
98,098-001,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",50,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-002,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",21,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-003,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-004,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",54,Male,Black,No,Yes,Unable to contact,,Yes,Unable to contact participant,No,2
98,098-005,T2,"PENNVAX-GP  mo(0,1,3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-006,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",44,Male,White,No,Yes,Death,,Yes,Death,Yes,2
98,098-007,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-008,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",26,Male,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-009,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",50,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-010,T2,"PENNVAX-GP  mo(0,1,3,6)",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-011,P3,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-012,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",46,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-013,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",30,Male,White,No,,,,No,Scheduled exit visit/end of study,No,3
98,098-014,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",31,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-015,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",46,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-016,T2,"PENNVAX-GP  mo(0,1,3,6)",45,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-017,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-018,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-019,T2,"PENNVAX-GP  mo(0,1,3,6)",24,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-021,T2,"PENNVAX-GP  mo(0,1,3,6)",25,Male,White,No,Yes,Unable to contact,,Yes,Unable to contact participant,No,2
98,098-022,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",28,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-023,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",22,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-024,T2,"PENNVAX-GP  mo(0,1,3,6)",26,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-026,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",18,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-027,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",41,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-028,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",48,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-029,T2,"PENNVAX-GP  mo(0,1,3,6)",33,Male,White,No,Yes,Unable to contact,,Yes,Unable to contact participant,No,3
98,098-030,P4,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",33,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
98,098-031,T1,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",54,Male,White,No,,,,No,Scheduled exit visit/end of study,No,3
98,098-032,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-033,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-034,P2,"Placebo for PENNVAX-GP mo(0,1,3,6)",24,Male,White,No,,,,Yes,Unable to contact participant,No,4
98,098-035,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-036,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",36,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-037,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",48,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-038,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-039,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",28,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-041,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",48,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-042,T2,"PENNVAX-GP  mo(0,1,3,6)",33,Female,White,No,Yes,Other clinical event,,Yes,Participant refused further participatio,No,1
98,098-043,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",42,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-044,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",50,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-046,T2,"PENNVAX-GP  mo(0,1,3,6)",31,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-047,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",35,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-048,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-049,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",48,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,3
98,098-050,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",28,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-052,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",19,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-053,P1,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",45,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-054,T2,"PENNVAX-GP  mo(0,1,3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-055,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-056,T1,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-057,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",28,Female,Asian,Yes,,,,No,Scheduled exit visit/end of study,No,4
98,098-058,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",28,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-059,T2,"PENNVAX-GP  mo(0,1,3,6)",35,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-060,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",29,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-061,T2,"PENNVAX-GP  mo(0,1,3,6)",27,Male,White,No,Yes,Incarceration,unable to adhere to visit schedule.,Yes,Participant unable to adhere to visit sc,No,3
98,098-062,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",41,Male,Black,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-063,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Female,Multiracial,Yes,,,,No,Scheduled exit visit/end of study,No,4
98,098-064,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-065,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Female,White,Yes,,,,No,Scheduled exit visit/end of study,No,4
98,098-066,T2,"PENNVAX-GP  mo(0,1,3,6)",41,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-067,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",34,Male,Black,No,,,,Yes,Unable to contact participant,No,4
98,098-068,T2,"PENNVAX-GP  mo(0,1,3,6)",34,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-069,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",22,Female,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-070,P3,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",27,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-071,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",23,Female,White,No,Yes,Refused,,No,Scheduled exit visit/end of study,No,1
98,098-072,T2,"PENNVAX-GP  mo(0,1,3,6)",21,Female,Asian,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-073,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",18,Male,Multiracial,Yes,,,,No,Scheduled exit visit/end of study,No,4
98,098-074,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",41,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-075,T1,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",24,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-076,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",27,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-077,T1,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",30,Male,White,No,,,,Yes,"Other, specify",No,4
98,098-078,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",30,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-079,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",40,Female,Black,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-080,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",19,Male,Multiracial,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-081,P4,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-082,T2,"PENNVAX-GP  mo(0,1,3,6)",18,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-083,P2,"Placebo for PENNVAX-GP mo(0,1,3,6)",26,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-084,T2,"PENNVAX-GP  mo(0,1,3,6)",24,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-085,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",51,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-086,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",19,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-087,T2,"PENNVAX-GP  mo(0,1,3,6)",20,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-088,T2,"PENNVAX-GP  mo(0,1,3,6)",35,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-090,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-091,T1,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",40,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-092,T2,"PENNVAX-GP  mo(0,1,3,6)",23,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-093,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",48,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-094,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",25,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-095,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",26,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-096,T3,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",34,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-097,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",18,Male,Multiracial,No,Yes,Unable to contact,,Yes,Unable to contact participant,No,3
98,098-098,P4,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",23,Male,Asian,No,,,,Yes,Unable to contact participant,No,4
98,098-099,T4,"PENNVAX-GP + IL-12 DNA mo(0,1,3,6)",30,Female,White,No,,,,No,Scheduled exit visit/end of study,No,4
98,098-100,P3,"Placebo for PENNVAX-GP / IL-12 DNA  mo(0,1,3,6)",26,Male,White,No,,,,No,Scheduled exit visit/end of study,No,4